Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation process of human immunoglobulin for intravenous injection

A human immunoglobulin and preparation process technology, applied in the field of biopharmaceuticals, can solve the problems of affecting the biological activity of intravenously injected human immunoglobulin, affecting the safety of clinical use of the product, and the inability to effectively remove viruses, so as to improve the appearance of the product, improve the Product safety, loss reduction effect

Active Publication Date: 2019-04-05
GUIZHOU TAIBANG BIOLOGICAL PROD
View PDF10 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] At present, in the preparation process of intravenous human immunoglobulin, S / D is often used to inactivate (some foreign blood product companies choose to inactivate the virus for 6 hours at 30°C), or use nano-membrane filtration to remove the virus, However, the S / D inactivation takes a long time and the effect is relatively general, which is likely to affect the biological activity of intravenously injected human immunoglobulin. When using nano-membrane filtration to remove viruses, some viruses cannot be effectively removed, which affects the safety of clinical use of the product.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation process of human immunoglobulin for intravenous injection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] (1) Take 1kgCohn component I+II+III / II+III as raw material;

[0034] (2) Dissolve Cohn component I+II+III / II+III with 10 times water for injection, adjust pH=4.0 with acetic acid, and press filter to get the filtrate;

[0035] (3) in filtrate, add octanoic acid to make filtrate concentration be 20mmol / L, regulate filtrate pH to 4.8 with NaOH, add filter aid, press filtration;

[0036] (4) Adjust the pH of the filtered filtrate to 4.0, and incubate at 37° C. for 9 hours;

[0037] (5) The filtrate after hatching is first carried out EMD DEAE chromatography, then carries out EMD TMAE chromatography, controls twice chromatography speed 150cm / h, during DEAE chromatography, solution is adjusted the pH of 5.1, and during TMAE chromatography, solution Adjust to a pH of 5.9, and maintain a conductivity of 1.8mS / cm during two chromatographic runs;

[0038] (6) collect the flow-through liquid through two chromatography, carry out ultrafiltration dialysis concentration;

[0039]...

Embodiment 2

[0043] (1) Take 1kgCohn component I+II+III / II+III as raw material;

[0044] (2) Dissolve Cohn component I+II+III / II+III with 8 times water for injection, adjust pH=3.8 with acetic acid, and take the filtrate by deep filtration;

[0045] (3) in filtrate, add octanoic acid to make filtrate concentration be 20mmol / L, regulate filtrate pH to 4.8 with NaOH, add filter aid, press filtration;

[0046] (4) Adjust the pH of the filtered filtrate to 4.0, and incubate at 37° C. for 6 hours;

[0047] (5) The filtrate after hatching is first carried out EMD DEAE chromatography, then carries out EMD TMAE chromatography, controls twice chromatography speed 100cm / h, during DEAE chromatography, solution is adjusted to the pH of 4.8, and during TMAE chromatography, solution Adjust to a pH of 5.6, and maintain a conductivity of 1.6mS / cm during two chromatography;

[0048] (6) collect the flow-through liquid through two chromatography, carry out ultrafiltration dialysis concentration;

[0049]...

Embodiment 3

[0053] (1) Take 1kgCohn component I+II+III / II+III as raw material;

[0054] (2) Dissolve Cohn component I+II+III / II+III with 12 times water for injection, adjust pH=4.2 with acetic acid, and take the filtrate by deep filtration;

[0055] (3) in filtrate, add octanoic acid to make filtrate concentration be 20mmol / L, regulate filtrate pH to 4.8 with NaOH, add filter aid, press filtration;

[0056] (4) Adjust the pH of the filtered filtrate to 4.0, and incubate at 37° C. for 12 hours;

[0057] (5) The filtrate after hatching is first carried out EMD DEAE chromatography, then carries out EMD TMAE chromatography, controls twice chromatography speed 200cm / h, during DEAE chromatography, the pH of solution adjustment 5.4, during TMAE chromatography, solution Adjust to a pH of 6.2, and maintain a conductivity of 2.0 mS / cm during two chromatography;

[0058] (6) collect the flow-through liquid through two chromatography, carry out ultrafiltration dialysis concentration;

[0059] (7) ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pore sizeaaaaaaaaaa
pore sizeaaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of medicine, in particular to a preparation process of human immunoglobulin for intravenous injection. Octanoic acid is used for replacing ethanol as a precipitatingagent, so that acidic protein in blood plasma generates precipitates; IgG molecules with high isoelectric points are reserved on supernate; only through one-step precipitation reaction, the materialscan be transferred to a chromatography working procedure; caprylate is used; lipid envelope viruses are inactivated under the mild condition in short time; even partial non-lipid envelope viruses canbe inactivated; the action time is short; the effect is good; the bioactivity of the immunoglobulin cannot be easily influenced; the product safety is improved; the quality and the yield of the product are ensured; a two-step chromatography working procedure is used; most partial polymers and other impure protein are removed; the pyrogen is reduced; chromoprotein such as ceruloplasmin can be adsorbed; the product appearance is effectively improved; one-step precipitation reaction is used; the loss is reduced; the product yield is improved; the preparation process of human immunoglobulin for intravenous injection has the advantages of high product yield, high purity and high safety.

Description

technical field [0001] The invention relates to the field of biopharmaceuticals, in particular to a preparation process for intravenous injection of human immunoglobulin. Background technique [0002] Human immunoglobulin (Immunoglobulin, Ig) is the main substance of the human body's immune response to foreign antigens (such as bacteria, viruses and their toxins or foreign substances), also known as antibodies. Immunoglobulins can be divided into 5 categories according to their structures, named IgG, IgA, IgM, IgD and IgE respectively. Among them, IgG has the highest content, accounting for about 70-80% of the total serum immunoglobulins, and is an important plasma immunoglobulin. one of protein. The content in plasma is about 6.6-14.5g / L. IgG is mainly synthesized by plasma cells in the spleen and lymph nodes. It is composed of four peptide chain molecules, and the peptide chains are connected by disulfide bonds. The relative molecular mass is 150kD. [0003] The active i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/00C07K1/36C07K1/34C07K1/18
CPCC07K16/00
Inventor 陈云华刘勇容伟张尧邓靖赵学梅刘欣晏杨刚
Owner GUIZHOU TAIBANG BIOLOGICAL PROD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products